Research progress in clinical prevention of scar hyperplasia
10.3760/cma.j.cn114453-20200312-00137
- VernacularTitle:瘢痕增生的临床预防研究进展
- Author:
Hefeng SUN
1
;
Qinghua YANG
Author Information
1. 中国医学科学院整形外科医院整形七科，北京 100144
- Keywords:
Cicatrix;
Hypertrophy;
Prevention;
Early intervention;
Recurrence
- From:
Chinese Journal of Plastic Surgery
2022;38(3):355-360
- CountryChina
- Language:Chinese
-
Abstract:
The pathological scars produced by scar hyperplasia are highly invasive, prone to recurrence, and often accompanied by itching and pain, which impose impact on patients’quality of life, physical and mental health. At present, it is generally believed that preventing the formation or recurrence of scars is the optimal way to deal with pathological scars. As a result, research on scar prevention is more worthy of attention. The author has collected relevant and instructive articles in the last 5 years and sorted them out by anti-scarring drugs, radiotherapy, laser therapy, in vitro non-invasive methods, discoveries and new clinical techniques, etc. All referenced articles focus on the prevention of scar hyperplasia and are closely connected with clinical practice. Summarization of the latest research and progress in this area has great significance for plastic surgeons.
